Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05865743 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Perioperative SDD to Prevent Infectious Complications After Esophagectomy

Study acronym: PERSuaDER
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Jun 2027 to Dec 31, 2027
    • Start date changed from estimate of Jun 2024 to Oct 21, 2024
    • Study sites: 0 to 2
    • Study completion date: Dec 2027 to Jun 30, 2028
  2. Start date: Sep 2023 to Jun 2024
    • Enrollment target: 853 to 854
    • Eligibility criteria expanded, about 68 words
    • Secondary endpoints revised (10)
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary aim of the PERSuaDER-trial is to evaluate the effect of SDD on infectious complications after esophagectomy, focussed on the prevention of pneumonia
Trial Details
NCT Number NCT05865743
Lead Sponsor Radboud University Medical Center
Collaborators: ZonMw: The Netherlands Organisation for Health Research and Development, Universitaire Ziekenhuizen KU Leuven
Conditions
(from sponsor)		 Esophageal Cancer
Related terms Esophageal Neoplasms
Enrollment 854 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov